Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Ajanta Pharma USA Inc recalls Fenofibrate Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • Fenofibrate Capsules
Where it was sold

U.S. Nationwide

Nationwide

Units affected
3648 bottles
About this recall
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.